Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
204.31M | 170.47M | 142.12M | 115.87M | 79.90M | Gross Profit |
145.88M | 116.09M | 88.84M | 66.50M | 45.45M | EBIT |
-31.41M | -34.37M | -49.70M | -50.39M | -39.57M | EBITDA |
-11.17M | -13.02M | -20.43M | -38.31M | -29.90M | Net Income Common Stockholders |
-28.35M | -31.03M | -49.74M | -51.69M | -41.77M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
99.13M | 108.84M | 113.34M | 136.00M | 55.70M | Total Assets |
188.93M | 201.01M | 208.35M | 187.49M | 92.97M | Total Debt |
56.06M | 59.54M | 73.56M | 25.04M | 18.44M | Net Debt |
4.46M | 8.79M | 11.57M | -110.95M | -37.26M | Total Liabilities |
121.96M | 122.06M | 125.13M | 75.18M | 54.98M | Stockholders Equity |
66.97M | 78.96M | 83.22M | 112.30M | 37.99M |
Cash Flow | Free Cash Flow | |||
11.96M | 6.53M | -15.89M | -30.18M | -19.38M | Operating Cash Flow |
14.15M | 10.22M | -12.77M | -20.37M | -15.52M | Investing Cash Flow |
8.88M | -7.74M | -54.03M | -9.81M | -3.86M | Financing Cash Flow |
-22.19M | -13.72M | -7.21M | 110.48M | -5.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $12.76B | ― | -1.24% | ― | 7.32% | 88.51% | |
62 Neutral | $1.74B | ― | -2.21% | ― | 14.44% | 84.58% | |
60 Neutral | $2.05B | ― | 16.58% | ― | 8.99% | 63.84% | |
60 Neutral | $353.50M | ― | -2.14% | ― | 24.52% | 61.08% | |
57 Neutral | $18.57B | 9.42 | -13.42% | 2.72% | 5.01% | -23.43% | |
56 Neutral | $695.40M | ― | -38.85% | ― | 19.85% | 13.78% | |
51 Neutral | $226.51M | ― | -40.78% | ― | -2.23% | 19.48% |
On February 20, 2025, Weave Communications announced its CFO, Alan Taylor, will retire by the end of the first quarter of 2025, with Vice President Jason Christiansen set to succeed him. The company also released its financial results for the fourth quarter and full year 2024, reporting a significant increase in revenue and improvements in operating income. Weave’s strategic investments in medical vertical markets and partnerships are expected to expand its market leadership and revenue opportunities in 2025.